NCT04210128View on ClinicalTrials.gov

Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Breast CancerPancreatic CancerDiabetesPre Diabetes
Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT04210128 - Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment | Biotech Hunter | Biotech Hunter